Exercise-Induced Epigenetic Modifications in Obese Aging Women (DIVAS2)
Primary Purpose
Metabolic Syndrome
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
High Protein Diet
Exercise
Sponsored by
About this trial
This is an interventional treatment trial for Metabolic Syndrome focused on measuring epigenetics, obesity, overweight, high protein diet, exercise, post menopausal women
Eligibility Criteria
Inclusion Criteria:
- Volunteer for the study
- Age between 50 and 64 years
- Self-identified as White or Caucasian
- Postmenopausal
- Sedentary (less than 1 hour each week of planned physical activity and sedentary job)
- BMI range >/= 25 kg/m2
- Waist circumference >88cm
- Weight stable (within 2 kg) for 6 months
- All allowable medications stable for 3 months
- Live independently
- Willing and able to obtain transportation to and from lab sessions
- Obtains physician clearance to participate in the study
Exclusion Criteria:
- Tobacco use
- Normal weight (BMI < 25 kg/m2)
- Males
- Dietary restrictions that do not allow for the consumption of beef, as required by our dietary protocol
- Weight loss surgery and/or weight loss medications usage
- Mini-mental state exam score < 25
- Recent or history of unstable CVD
- Cancer treatment within the last 5 years or active cancer
- History of lung disease or COPD or severe asthma
- History or severe arthritis or other medical condition that precludes ability to exercise to level needed by study.
- Current diagnosis or history of balance disorders
- History of mental disorders, dementia, clinical depression or other disorders that preclude adherence to protocols.
- Current weight of 350 pounds or greater, due to weight restrictions on equipment.
Sites / Locations
- Body Composition and Metabolism Lab, UGA, Ramsey Student Center
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
High Protien Diet + Exercise
Arm Description
All participants will participate in both interventions (High Protein Diet and Exercise).
Outcomes
Primary Outcome Measures
Change in CD4+T Cells from Baseline to Post-Intervention
The primary aim is to determine if CD4+ T cells will report the differential epigenetic reprogramming of relevant gene expression associated with metabolic indices resulting from EX+CR induced weight loss in older women known to be at risk for MetS.
Secondary Outcome Measures
Change in Physical Function over 6 Months
A secondary aim is to assess the impact of weight loss on physical function, which will provide pilot data for an additional grant proposal regarding weight management in postmenopausal women.
Change in Psychological Well Being over 6 Months
A battery of psychological assessments will be administered at three time points throughout the study to evaluate possible changes in psychological well being throughout the intervention.
Full Information
NCT ID
NCT01977885
First Posted
October 16, 2013
Last Updated
September 24, 2015
Sponsor
University of Georgia
1. Study Identification
Unique Protocol Identification Number
NCT01977885
Brief Title
Exercise-Induced Epigenetic Modifications in Obese Aging Women
Acronym
DIVAS2
Study Type
Interventional
2. Study Status
Record Verification Date
September 2015
Overall Recruitment Status
Completed
Study Start Date
June 2013 (undefined)
Primary Completion Date
December 2014 (Actual)
Study Completion Date
December 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Georgia
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Our greatest public health challenge is obesity and the co-morbidities of metabolic syndrome (MetS). Age is an established risk factor for MetS and specific to women, data indicates that the prevalence of MetS increases substantially with the menopausal transition with postmenopausal women having a 60% increased risk of MetS. Menopause also contributes to reductions in strength, physical function and often psychological well-being (e.g. fatigue). Obese individuals also have: a) impaired immune function and chronic inflammatory responses associated with changes in the white blood cell population in blood and fat tissues; and, b) increased secretion of and signaling by proteins in their fat cells. Weight loss, which requires an energy deficit through increased physical activity and/or caloric restriction (EX+CR), reduces risk for MetS in older sedentary obese women by reducing insulin resistance and chronic systemic inflammation. Science and clinical practice will be advanced by examining the molecular mechanisms by which EX+CR affects risk for MetS in older women. The primary aim is to determine if CD4+ T cells will report the differential epigenetic reprogramming of relevant gene expression associated with metabolic indices resulting from EX+CR induced weight loss in older women known to be at risk for MetS. This pilot data will be used to generate an NIH proposal of the same topic. A secondary aim is to assess the impact of weight loss on physical function and psychological well-being which will provide pilot data for an additional grant proposal regarding weight management in postmenopausal women.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Metabolic Syndrome
Keywords
epigenetics, obesity, overweight, high protein diet, exercise, post menopausal women
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
21 (Actual)
8. Arms, Groups, and Interventions
Arm Title
High Protien Diet + Exercise
Arm Type
Experimental
Arm Description
All participants will participate in both interventions (High Protein Diet and Exercise).
Intervention Type
Behavioral
Intervention Name(s)
High Protein Diet
Intervention Description
All participants will be individually counseled by an RD for ~ 4 sessions (30 to 60 minutes)to meet weight loss goals. During the duration of the study, participants will be required to attend a 30 to 60 minute group educational/motivational meeting weekly (first 1 to 2 months) and then biweekly (for the remainder of the study). Diet recommendations will include high quality proteins with an emphasis on lean meats with protein being targeted for every meal and snack. Regarding beef intake specifically, the prescribed diet will include a minimum of one serving of beef per day, which is approximately 3 to 3.5 ounces or ~100 grams. This amount of lean cooked beef provides an average of ~25-30 grams of protein per day (www.beefnutrition.org/leanbeef.aspx). This combined with reducing energy from carbohydrates and fat from other sources will create an overall energy deficit of 500 kcal/day. This diet will also include 5 servings/day of vegetables and 2-3 servings/day of fruit
Intervention Type
Behavioral
Intervention Name(s)
Exercise
Intervention Description
Participants will be prescribed a supervised exercise program with required attendance of 3 nonconsecutive days per week (75 minutes each session). A program that combines flexibility and balance activities, weight bearing endurance exercise (walking) and resistance training to preserve lean mass will be prescribed. With specific regard to strength training, 50% of the resistance work will involve primary muscle groups of the lower body with the main focus being the gluteal and quadriceps groups (squats, lunges, etc.). The remaining 50% of work will dedicate 25% to the core stabilizers with the final 25% being the upper body. Transitions between segments of training will be used for recovery and social support enhancement. Note that all aspects of the exercise intervention will be progressive in intensity (i.e., starting at lower end of intensity or ~50% of maximal capacity), and duration (i.e., from 15 minutes to 35 minutes of exercise and adding a few minutes each session).
Primary Outcome Measure Information:
Title
Change in CD4+T Cells from Baseline to Post-Intervention
Description
The primary aim is to determine if CD4+ T cells will report the differential epigenetic reprogramming of relevant gene expression associated with metabolic indices resulting from EX+CR induced weight loss in older women known to be at risk for MetS.
Time Frame
Baseline (Week 0), Post-Intervention (Week 24)
Secondary Outcome Measure Information:
Title
Change in Physical Function over 6 Months
Description
A secondary aim is to assess the impact of weight loss on physical function, which will provide pilot data for an additional grant proposal regarding weight management in postmenopausal women.
Time Frame
Baseline (Week 0), Midpoint (Week 12), Post-Intervention (Week 24)
Title
Change in Psychological Well Being over 6 Months
Description
A battery of psychological assessments will be administered at three time points throughout the study to evaluate possible changes in psychological well being throughout the intervention.
Time Frame
Baseline (Week 0), Midpoint (Week 12), Post-Intervention (Week 24)
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
64 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Volunteer for the study
Age between 50 and 64 years
Self-identified as White or Caucasian
Postmenopausal
Sedentary (less than 1 hour each week of planned physical activity and sedentary job)
BMI range >/= 25 kg/m2
Waist circumference >88cm
Weight stable (within 2 kg) for 6 months
All allowable medications stable for 3 months
Live independently
Willing and able to obtain transportation to and from lab sessions
Obtains physician clearance to participate in the study
Exclusion Criteria:
Tobacco use
Normal weight (BMI < 25 kg/m2)
Males
Dietary restrictions that do not allow for the consumption of beef, as required by our dietary protocol
Weight loss surgery and/or weight loss medications usage
Mini-mental state exam score < 25
Recent or history of unstable CVD
Cancer treatment within the last 5 years or active cancer
History of lung disease or COPD or severe asthma
History or severe arthritis or other medical condition that precludes ability to exercise to level needed by study.
Current diagnosis or history of balance disorders
History of mental disorders, dementia, clinical depression or other disorders that preclude adherence to protocols.
Current weight of 350 pounds or greater, due to weight restrictions on equipment.
Facility Information:
Facility Name
Body Composition and Metabolism Lab, UGA, Ramsey Student Center
City
Athens
State/Province
Georgia
ZIP/Postal Code
30602
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Exercise-Induced Epigenetic Modifications in Obese Aging Women
We'll reach out to this number within 24 hrs